)明显降低，IP 2. 27 mmol/L(0. 81 ??1. 61) 增高，Mg 0.70mmol/L(0. 6??1. 2);24h 尿 CA... 528/56lms);血 CK 56U/U CA 24mmol/L,IP 2.06mmol/L。图2 QT间期较前缩短讨论该病

化验尤其是采集手指血时，宜在抗凝管中稳定 2 分钟左右使抗凝充分了再用仪器检测，否则容易出现单核细胞假性升高。24检测 TB/DB 时标本要避免强光直射，不要放在

。·β肾上腺素能活性升高。· 细胞外酸碱度升高。参考文献为：1.Mount DB, Zandi-Nejad K.... Pharmacol 2010; 24:595.3.Adrogué HJ, Lederer ED, Suki WN, Eknoyan G.

01硝酸甘油 (5 mg:1 mL)6 支 + NS 24 mL 至 30 mL iv 泵入，0.6 mL/h 相当于 10 μg/min，起始剂量 5～10...垂体后叶素 (6U:1 mL)10 支 + NS 至 30 mL iv 泵入，3 mL/h 相当于 0.1 U/min，消化道出血常用剂量 0.2

NIH基金项目申报研修班”将于2014年10月24—26日在北京举办。参加培训人员可获得国家级继续教育I类学分8分。&nbsp...年10月24—26日（24日下午报到）。2.授课地点：北京中医药大学3.培训费用：1200元（含报名、培训、场地、讲义、证书

分子流行病学再揭示人类复杂疾病遗传因素及其与环境因素相互作用发挥重要作用,为人类疾病的风险评估、预防和个性化治疗提供依据。全基因组关联分析（GWAS）为全面系统研究复杂疾病的遗传因素掀开了新的一页，为我们了解人类复杂疾病的发病机制提供了更多的线索。科学家已经在肥胖、糖尿病、冠心病、阿尔茨海默、乳腺癌、前列腺癌、肺癌、胃癌等一系列复杂疾病中进行了全基因组关联研究并找到疾病相关的易感基因，我国科学家也在银屑病、精神病和冠心病等方面开展了GWAS研究并取得成效。国家科技部最新公布了“常见重大疾病全基因组关联分析和药物基因组学研究”的863重点项目，吹响了我国大规模开展GWAS研究的号角。为了让更多的相关研究人员，特别是广大研究生了解GWAS的研究原理和方法，学会设计GWAS的研究和分析实验结果，同时在癌症领域分享海内外研究专家们的成功经验，并期待在GWAS方面进行交流合作,复旦大学和美国Van Andel 研究所将于2009年7月12-14日在上海联合举办上海分子流行病学与GWAS国际 研讨会, 期待各位同道免费参加，请有意者及时将回执返回联系邮箱。免注册费（食宿餐饮费用自理）。名额有限，报名从速！时间： 2009年7月12－14日
报到地点： 复旦大学卿云楼宾馆 上海市邯郸路220号，200433
会议地点： 复旦大学逸夫楼报告厅
联 系 人： 赵雪莹 高歌 联系电话： 021-55664495
回执邮箱： GWAS2009@gmail.com
BackgroundRecent success of genome-wide association studies (GWAS) in the U.S. and Europe has lead to the identification of a large number of genetic variants that are associated with disease risk and progression, including those for cancer and cardiovascular diseases. The discovery of these genetic markers not only improves our understanding of disease etiology, but also contributes significantly to risk prediction, early detection, and targeted treatment of diseases.Although GWAS have been used in Chinese populations to identify Chinese-specific risk-associated genetic variants for several common diseases such as breast cancer and psoriasis, many more GWAS are needed for various diseases. A better understanding of the importance of GWAS and a better knowledge of study design and data analysis of GWAS will further promote broad application of GWAS in China. This symposium which will cover genetic epidemiology and GWAS in China is organized to serve this purpose. We have invited a group of experts in this area from the U.S. and China to share their experience in GWAS, and we hope to foster an environment which will encourage an open discussion among all participants.
Objectives• To better understand the potential applications of GWAS
• To address practical issues in study design, implementation, and data analysis of GWAS
• To promote interaction and collaboration among researchers who are interested in GWAS
• To explore other important studies after GWAS: gene-environment interaction, risk prediction, and functional analyses
• To consider issues and implications related to genomic and personalize medicine
Organizing committeeThe organizing committee consists of four members:
Dr. Jianfeng Xu (Co-Chair)
Dr. Daru Lu (Co-Chair)
Dr. Li Jin (Co-Chair ,Advisor)
Dr. Qingyi Wei (Co-Chair, Advisor)
PresentationsSession I: Genetic epidemiology and GWAS of cancer
• Breast cancer in Chinese populations Xiao-ou Shu
• Genetic association studies of skin cancer Jiali Han
• Genetic variants in the MC1R gene and risk of cutaneous melanoma Qingyi Wei
• Genetic association studies of lung cancer in Chinese populations Daru Lu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao Zhou
• Molecular epidemiology of stomach cancer Weimin YeSession II: Genetic epidemiology and GWAS of other diseases
• Genetic association studies of hypertension in Chinese populations Jiang He
• GWAS of Autoimmune Diseases (Psoriasis, etc.) in Chinese populations Wei Huang
• Molecular epidemiology of diabetes in Chinese populations Weiping Jia
• Molecular genetics study of hypertension in Chinese populations Dingliang Zhu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao ZhouSession III: Post-GWAS studies
• Genetic structure of Chinese population Li Jin
• High-throughput genotyping for GWAS and fine mapping studies Siqun Lilly Zheng
• Molecular genetics study of neural tube defect Hongyan Wang
• Risk prediction using genetic variants in prostate cancer Jianfeng Xu
• Gene-environmental interaction in smoking related cancer Zuo-Feng Zhang
• Cancer Somatic Genomics Bin TehSession IV: Short presentations by participants and discussion
Registration时　　间： 2009年7月12－14日
报到地点： 复旦大学卿云楼宾馆大厅 上海市邯郸路220号 (200433)
会议地点： 复旦大学逸夫楼报告厅
联 系 人： 赵雪莹，高歌 (Shanghai, China)；Tamara Adams (U.S.)
联系电话： 21-55664495 (Shanghai, China)；336-713-7532 (U.S.)
回执邮箱： GWAS2009@gmail.com (Shanghai, China)；tsadams@wfubmc.edu (U.S.)
Invited speakers (alphabetic)• Jiali Han, Ph.D., is an Assistant Professor of Medicine at Harvard Medical School. His major research areas are:
• Genetic epidemiology of skin cancer and breast cancer
• Genome-wide association studies
• Gene-environment interaction• Jiang He, M.D. Ph.D., is a Professor and Chair of Epidemiology, Tulane University School of Public Health., U.S.A. His major research areas are:
• Genetic epidemiology of hypertension
• Gene-nutrition interaction of cardiovascular disease• Wei Huang, Ph.D., is a Professor and Executive Deputy Director of Chinese National Human Genome Center at Shanghai, China. Her major research areas are:
• Genetic susceptibility to autoimmune diseases, cardiovascular diseases and cancer.
• Genome-wide association studies
• Genetic variants and association study• Weiping Jia M.D., is a professor of endocrinology at Shanghai Institute of Diabetes, Shanghai No.6 People’s Hospital, Shanghai Jiaotong University, Her major research area is:
• Molecular endocrinology and diabetes• Li Jin, Ph.D, is a Professor of Genetics and vice President of Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolism diseases
• Genetic markers for population genetics• Daru Lu, Ph.D, is a Professor of Genetics and Vice Dean of School of Life Sciences, Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolic disease• Xiao-ou Shu, M.D, Ph,D, is a Professor of Medicine in the Department of Medicine at the Vanderbilt University School of Medicine, U.S.A. Her major research areas are:
• Genetic and lifestyle predictors of cancer and other chronic diseases
• Cohort study methodology
• Incorporating biomarkers in risk prediction• Bin Teh, M.D, is a Distinguished Scientific Investigator at Van Andel Institute, U.S.A. His major research areas are:
• Translational cancer research
• Gene expression profiling
• Cancer genome high-throughput sequencing• Hongyan Wang, Ph.D, is a professor of genetics at School of Life sciences, Fudan University, China. Her major research area is:
• Molecular genetics and epidemiology of birth defects (deformity of neural tube, congenital heart disease, etc.)• Qingyi Wei, M.D, Ph.D, is a Professor of Epidemiology at The University of Texas M. D. Anderson Cancer Center, U.S.A. His major research areas are:
• Molecular epidemiology of DNA repair, apoptosis, and skin cancer and head and neck cancer
• Genetic susceptibility to cancer
• DNA repair and apoptosis phenotype markers• Jianfeng Xu, M.D, Dr.PH, is a Professor of Epidemiology and Cancer Biology and Director of the Center for Cancer Genomics at Wake Forest University School of Medicine, U.S.A. His major research areas are:
• Genetic epidemiology of prostate cancer
• Genome-wide association and fine mapping analysis
• Risk prediction using genetic markers and other clinicopathologic variables• Zuo-Feng Zhang, M.D., Ph.D, is a Professor of Epidemiology at UCLA School of Public Health, U.S.A. His major research areas are:
• Molecular epidemiology of smoking-related cancers
• Confirmation studies of SNPs identified in genome-wide association studies in smoking-related cancers
• Gene-environmental interaction between genetic markers and environmental factors• S. Lilly Zheng, M.D, is a Professor of Medicine and Director of the Genotyping Laboratory at Wake Forest University School of Medicine. U.S.A. Her major research areas are:
• High-throughput genotyping and sequencing
• Genetic epidemiology of prostate cancer• Gangqiao Zhou, Ph.D, is a Professor of Medical Genetics and Genomics in National Academy of Military Medical Science. His major research area is:
• molecular and genetics of complex diseases• Dingliang Zhu, M.D, is a professor of cardiology at Shanghai Institute of Hypertension, Shanghai, China. His major research area is:
• Molecular and genetics of cardiovascular diseases• Weimin Ye, Ph.D, is a Professor of Medical Epidemiology at Karolinska Institutet, Sweden. His major research areas are: Etiology of upper gastrointestinal diseases
• Topic of presentation: Molecular epidemiology of stomach cancer

6 月 22 日 会议时间：2018 年 6 月 23-24 日 会议地点：北京国际会议中心（BICC）一层第三会议厅 学分授予：国家级继续医学教育学分 I 类...2018 北京男科论坛 2018 年 6 月 22-24 日 北京国际会议中心（BICC）基本信息 主办单位：中华医学会北京分会 

山东省抗癌协会泌尿男生殖系肿瘤分会定于2013年5月24日-26日在山东省济南市召开山东省抗癌协会泌尿男生殖系肿瘤分会第三次学术交流会议暨首届齐鲁泌尿肿瘤论坛。届时将邀请全国泌尿男生殖系肿瘤领域权威专家到会，就泌尿男生殖系肿瘤领域的最新诊治进展进行交流。会议结束将获得省级继续医学教育I类学分

M R I-17病理进程-6CT-16病理-5病因-4超声显像-13定义-3肝活检-24后向血流学说-8

、妊娠期及哺乳期妇女应避免使用本类药物[24]；大多药品说明书规定氟喹诺酮类抗菌药物不宜用于、避免用于或禁用于18岁以下的小儿及青少年。儿童不应完全禁用氟喹诺酮...高的抗菌药物。⑤急性细菌性鼻窦炎美国传染病学会（IDSA）推荐既往出现青霉素 I 型超敏反应、或初始经验治疗效果不佳/存在耐药的严重感染儿童，选择左

（2015版）》中关于氟喹诺酮药物的阐述为：18岁以下未成年患者、妊娠期及哺乳期妇女应避免使用本类 药物 [24] ；大多药品说明书...会（IDSA）推荐既往出现青霉素 I 型超敏反应、或初始经验治疗效果不佳/存在耐药的严重感染儿童，选择左氧氟沙星作为替代阿莫西林克拉维酸的二线药物 [46] 。儿童

主诉：患者，男性，23岁，因“乏力、纳差、尿黄4天”于2011年11月24日入院。现病史：患者因过度疲劳饮酒后，自觉全身乏力、纳差、厌油、尿黄4日，时有右季肋部不适，于2011年11月24日在泗阳县人民医院就诊。查体示：巩膜中度黄染，咽部充血，扁桃体

发现：主要呼吸道上皮细胞的介质合成能力因其所处位置和分化程度的不同而不同，但没有疾病的特异性。核因子抑制剂IKK2i可以弱化由促炎细胞因子和TLR3受体激动剂所引起的上皮细胞合成能力的激活，但糖皮质激素治疗则没有这样的作用。作者认为，核因子抑制剂IKK2i可能为支气管哮喘的治疗提供一个重要的新方法。用于该研究的

3 月 6 日 22:52，警笛长鸣的救护车，将一位 81 岁高龄的老人黄某某送入了广西中医药大学第一附属医院东葛院区急诊科的大门。这是一位已经没有了心跳和呼吸的老人，急诊团队随即展开了争分夺秒的抢救，进行心肺复苏，很快，患者恢复自主心律，患者从生死线上好不容易回来了，但存在严重的恶性心律失常—三度

患者 81 岁，有冠心病、陈旧下后壁心梗，使用华法林 0.75mg/d 抗凝，INR 稳定，无口腔、黏膜下出血，无尿血、便血。近期因十二指肠球溃疡入消化科治疗，接受奥美拉唑治疗 3 d 后，患者出现血便，INR 8.5 ，PT 140.6 s 。你会如何处理？众所周知，质子泵抑制剂有酶抑制作用。在本案例中，奥美拉唑

将医疗机构IT化是奥巴马政府推广的美国医改的重要组成部分。至今为止，美国政府已经出资81亿美元将患者的信息输入电子病历。然而，《华盛顿邮报》最近的报道指出，医疗机构对于IT安全的重视度并没有跟上。《华盛顿邮报》的报道指出，医疗机构对电子安全的重视

政策驱动 产业机遇作为2012年中国医药行业年度峰会第一站活动--“2012医改政策解读暨基本药物制度发展高峰论坛”将于2012年4月24日在安徽合肥与第67届全国药品交易会、第68届中国国际医药原料药、中间体、包装、设备交易会

2011年妇产科急重症诊治进展学习班课程表.doc上海交通大学医学院附属国际和平妇幼保健院2011年《妇产科急重症诊治新进展》学习班（国家级I类学分 10分）举办时间：2011年12月13 –17日"妇产科急重症"